MENU

Fox Chase Cancer Center Proudly Sponsors Miles for Melanoma Philadelphia 5K

August 17, 2021

Dr. Jeffrey M. Farma, co-director of the Melanoma and Skin Cancer Program at Fox Chase, leads the Fox Chase Miles for Melanoma team.Dr. Jeffrey M. Farma, co-director of the Melanoma and Skin Cancer Program at Fox Chase, leads the Fox Chase Miles for Melanoma team.

PHILADELPHIA (August 17, 2021) - Fox Chase Cancer Center is proud to be a local sponsor and continued supporter of the annual Miles for Melanoma Philadelphia 5K, which will take place both in person and online this year.

The fundraising event, benefitting the Melanoma Research Foundation, is in line with Fox Chase’s dedication to spreading awareness and increasing education and research on skin cancer.

The center’s team for the race is made up of melanoma patients, survivors and healthcare professionals. It will be led by Jeffrey M. Farma, MD, FACS, chief of the Division of General Surgery and co-director of the Melanoma and Skin Cancer Program at Fox Chase.

“I am so excited to captain the Fox Chase Cancer Center team for the 2021 Miles for Melanoma Philadelphia 5K,” Farma said. “I am looking forward to seeing everyone in person to raise money and awareness for melanoma research, advocacy, and education.”  

On August 28, 2021, the in-person participants will walk at the Philadelphia Zoo, while remote participants can join from anywhere. To comply with guidelines from the Philadelphia Health Department, this year’s race will be walk only.

All Fox Chase community members are welcome to join Fox Chase’s team. Registration for the event is $35 and includes admission to the Philadelphia Zoo. If you are interested in joining the Fox Chase team, making a donation, or learning more about the 5K, visit: https://www.foxchase.org/events/miles-for-melanoma-2021.

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase